Q
Quematics
CWVA — Prevention Evidence Dashboard
Pilot 2026
Live · April 2026
Ryan Gould — CWVA
NHS Strategic Commissioning Framework — April 2026
From probable savings to commissioner-grade evidence to a closed NHS prevention loop
15 VCSE organisations · Cheshire West · Pilot cohort 2026
Performance Productivity Outcomes Impact Equity Data Quality Value for Money
Three evidence tiers
Tier 1 · Retrospective
Probable savings
NASP benchmarks applied to existing activity data. Estimated system savings before evidenced outcomes exist.
£127k
Estimated system saving
500+
People supported
20%
Prevention rate
View →
Tier 2 · Prospective
Evidenced outcomes
Actual WEMWBS scores, referral decisions, non-escalations. Documented at point of service. Commissioner-grade.
+8.4
Avg WEMWBS gain
73%
Non-escalation rate
312
Outcomes recorded
View →
Tier 3 · Referral Loop
Closed NHS loop
Enhanced Case Finding Tool cohorts referred into VCSE network. Outcomes tracked and reported back to Data into Action.
48
High-risk referrals
Q1
First report due
0
Mechanism existed
View →
Network headline KPIs
Orgs in pilot
15
of 375 CWVA members
↑ Target: 15–20
People supported
763
across pilot network
↑ Q1 2026
Data quality score
84%
field completeness
↑ from 41% baseline
Est. system saving
£127k
modelled · NASP rates
£4 : £1 NASP ratio
ICB 2026 evidence domain scores
Performance
82%
Productivity
74%
Outcomes (PROMs)
68%
Impact
71%
Equity
59%
Data Quality
84%
Value for Money
91%
Referral source breakdown
GP / Primary care
34%
Self-referral
28%
Social prescribing
19%
ICT / Enhanced CF
11%
Other VCSE
8%
Tier 1 · Retrospective modelling
Probable system savings — early estimate
NASP benchmark rates applied to existing activity data. Not evidenced outcomes — a meaningful opening figure for the ICB conversation.
£127k
Estimated system saving · Q1 2026
People supported
763
across 15 pilot orgs
Prevention rate
20%
conservative NASP estimate
GP appts avoided
~153
@ £35 each = £5,355
A&E avoided
~61
@ £175 each = £10,675
NASP benchmark rates applied
GP reduction
42%
A&E reduction
23%
Frequent users
50%
ROI (NASP)
£4:£1
Estimated saving by intervention type
Mental health drop-in
£51k
Befriending
£32k
Food & crisis
£26k
Social prescribing
£18k
NHS reference costs used in modelling
Cost itemNHS unit costEstimated avoidedEstimated savingSource
GP appointment£30–40~153£5,355NASP
A&E attendance£150–200~61£10,675NASP
CAMHS referral£800+~14£11,200Estimated
Inpatient admission£2,500+~5£12,500Estimated
Tier 2 · Prospective outcome measurement
Commissioner-grade evidence — documented at point of service
Actual before-and-after WEMWBS scores. Actual referral decisions. Actual non-escalations. Not modelled approximations.
Avg WEMWBS gain
+8.4
baseline → exit
↑ Clinically significant
Non-escalation rate
73%
intervention resolved without NHS referral
Outcomes recorded
312
complete baseline + exit pairs
↑ 84% field completeness
Referrals avoided
228
documented non-escalation decisions
WEMWBS outcomes by organisation — baseline vs exit
OrganisationPeopleBaseline scoreExit scoreGainStatus
Community drop-in A5238.246.8+8.6Strong
Befriending service B4135.443.1+7.7Strong
Food bank C6732.141.5+9.4Strong
Social prescribing D3840.347.9+7.6Good
Wellbeing hub E2936.842.5+5.7Moderate
Referral decision breakdown
Resolved in community
73%
Referred to GP
14%
Referred to specialist
8%
Referred to A&E
5%
Demographic completeness (equity domain)
Age captured
96%
Postcode captured
88%
Ethnicity captured
71%
Referral source
84%
WEMWBS at exit
79%
Tier 3 · Referral loop closure
Closing the loop that currently doesn't exist
Enhanced Case Finding Tool cohorts → VCSE network → tracked outcomes → reported back to Data into Action. Done by their team, on their platform.
Mechanism existed before
None
Enhanced Case Finding Tool
Data into Action identifies high-risk individuals. 65+, frailty, LTCs, frequent A&E users.
VCSE network receives referral
Community support delivered. Quematics records intervention at point of service.
Quematics tracks outcomes
WEMWBS, referral decisions, non-escalations. Structured and aggregated.
Quarterly report to Data into Action
Structured Excel export. Aggregate anonymised cohort data. ICB-ready.
High-risk referrals in
48
from Enhanced Case Finding Tool
Interventions delivered
44
92% of referrals engaged
Hospital avoided
~31
estimated from cohort outcomes
Next report due
Q2
April–June 2026 · Excel export
High-risk cohort profile
65+ deprived area
38%
Multiple LTCs
29%
Frequent A&E users
21%
Frailty risk
12%
WEMWBS outcomes — high-risk cohort
Strong improvement
41%
Moderate improvement
33%
Stable — no escalation
19%
Escalated to NHS
7%
NHS Strategic Commissioning Framework — April 2026
The 2026 accountability shift — all 7 domains
The era of activity reporting has ended. Evidence now determines whether a contract is renewed, expanded, or put to competitive tender.
Performance
Who was served, how many sessions, attendance rate
82%
Productivity
Capacity utilisation, staff hours, cost per person
74%
Outcomes (PROMs)
WEMWBS baseline vs exit. Validated outcome measure.
68%
Impact
Non-escalations, avoided cost, system savings
71%
Equity
Demographic completeness. Deprivation reach.
59%
Data Quality
Field completeness across all 7 required fields
84%
Value for Money
£4:£1 NASP ratio. £127k estimated saving.
91%
Overall readiness
Across all 7 ICB evidence domains
76%
What happens without each domain — commissioner consequence
DomainCurrent scoreGapCommissioner risk
Equity59%Ethnicity field 71% completeReview required
Outcomes (PROMs)68%Exit WEMWBS 79% capturedStrengthen evidence
Impact71%Non-escalation recording improvingOn track
Productivity74%Cost per person not yet fully costedOn track
Performance82%Strong. Session data complete.Strong
Data Quality84%Up from 41% at baselineStrong
Value for Money91%£4:£1 NASP modelled returnStrongest domain
Q
Ask Q
CWVA Prevention Evidence Intelligence
Live · Pilot 2026
Quick questions
Powered by Quematics Q Intelligence 0 / 20 questions